Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

HPLC separation of related impurities in etiprednol dicloacetate, a novel soft corticosteroid.

Patthy M, Seres G, Csanádi A, Szekeres T, Zubovics Z, Bodor N.

Pharmazie. 2004 May;59(5):382-6.

PMID:
15212306
2.

Potency and specificity of the pharmacological action of a new, antiasthmatic, topically administered soft steroid, etiprednol dicloacetate (BNP-166).

Kurucz I, Tóth S, Németh K, Török K, Csillik-Perczel V, Pataki A, Salamon C, Nagy Z, Székely JI, Horváth K, Bodor N.

J Pharmacol Exp Ther. 2003 Oct;307(1):83-92. Epub 2003 Jul 31.

3.

Etiprednol dicloacetate, a new soft glucocorticoid drug candidate. Development of chemistry.

Csanádi A, Horváth G, Szekeres T, Haskó T, Ila L, Ivanics J, Patthy M, Salát J, Seres G, Pallagi I, Tóth G, Szederkényi F, Kónya A, Tegdes A, Bodor N, Zubovics Z.

Pharmazie. 2004 May;59(5):349-59.

PMID:
15212300
4.

Anti-inflammatory effect and soft properties of etiprednol dicloacetate (BNP-166), a new, anti-asthmatic steroid.

Kurucz I, Németh K, Mészáros S, Török K, Nagy Z, Zubovics Z, Horváth K, Bodor N.

Pharmazie. 2004 May;59(5):412-6.

PMID:
15212312
5.

High perfomance liquid chromatography in pharmaceutical analyses.

Nikolin B, Imamović B, Medanhodzić-Vuk S, Sober M.

Bosn J Basic Med Sci. 2004 May;4(2):5-9.

PMID:
15629016
6.

A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.

Kumar AP, Ganesh VR, Rao DV, Anil C, Rao BV, Hariharakrishnan VS, Suneetha A, Sundar BS.

J Pharm Biomed Anal. 2008 Mar 13;46(4):792-8. doi: 10.1016/j.jpba.2007.11.029. Epub 2007 Nov 26.

PMID:
18191357
7.

Synthesis of a mixed-model stationary phase derived from glutamine for HPLC separation of structurally different biologically active compounds: HILIC and reversed-phase applications.

Aral T, Aral H, Ziyadanoğulları B, Ziyadanoğulları R.

Talanta. 2015 Jan;131:64-73. doi: 10.1016/j.talanta.2014.07.060. Epub 2014 Jul 31.

PMID:
25281074
8.

Estimation of impurity profiles of drugs and related materials Part 18. Impurities and degradation products of mazipredone.

Gazdag M, Babják M, Brlik J, Mahó S, Tuba Z, Görög S.

J Pharm Biomed Anal. 1998 Sep 1;17(6-7):1029-36.

PMID:
9884192
9.

Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity.

Lacroix PM, Dawson BA, Sears RW, Black DB, Cyr TD, Ethier JC.

J Pharm Biomed Anal. 1998 Nov;18(3):383-402.

PMID:
10096833
10.

An HPLC method to evaluate purity of a steroidal drug, loteprednol etabonate.

Yasueda S, Higashiyama M, Shirasaki Y, Inada K, Ohtori A.

J Pharm Biomed Anal. 2004 Oct 29;36(2):309-16.

PMID:
15496323
11.

Separation and estimation of process-related impurities of gefitinib by reverse-phase high-performance liquid chromatography.

Chandrashekara KA, Udupi A, Reddy CG.

J Chromatogr Sci. 2014 Sep;52(8):799-805. doi: 10.1093/chromsci/bmt116. Epub 2013 Jul 29.

PMID:
23897663
12.

Determination of local anaesthetics and their impurities in pharmaceutical preparations using HPLC method with amperometric detection.

Fijałek Z, Baczyński E, Piwońska A, Warowna-Grześkiewicz M.

J Pharm Biomed Anal. 2005 Apr 29;37(5):913-8. Epub 2005 Feb 12.

PMID:
15862666
13.

Development and validation of a HPLC method for the determination of sertraline and three non-chiral related impurities.

Ferrarini A, Huidobro AL, Pellati F, Barbas C.

J Pharm Biomed Anal. 2010 Oct 10;53(2):122-9. doi: 10.1016/j.jpba.2010.01.036. Epub 2010 Jan 25.

PMID:
20138727
15.

Synthesis of the impurities during the manufacture of bulk drug midazolam and separation of these impurities by HPLC.

Sati B, Sati H, Saklani S; Ellamma, Bhatt PC, Mishra R.

Acta Pharm. 2013 Sep;63(3):385-96. doi: 10.2478/acph-2013-0025.

PMID:
24152898
16.

A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.

Tan L, Wlasichuk KB, Schmidt DE Jr, Campbell RL, Hirtzer P, Cheng L, Karr DE.

J Pharm Biomed Anal. 2012 Jul;66:75-84. doi: 10.1016/j.jpba.2012.03.003. Epub 2012 Mar 10.

PMID:
22459505
17.
18.

Supplemental Content

Support Center